| Title | Date | PubMed ID |
|---|
| The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines. | 2012 Mar | 22718627 |
| Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro. | 2009 Jul | 19419757 |
| Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy. | 2009 Mar | 18992924 |
| Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X. | 2008 Jun | 18589871 |
| Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats. | 2006 Oct | 17061060 |
| Analysis of the relationship between cancer procoagulant activity and PCNA and Ki-67 expression in cases of common and cellular uterine leiomyomas. | 2006 | 17139986 |
| Cancer procoagulant in patients with adenocarcinomas. | 2005 Nov | 16269926 |
| Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro. | 2005 May 10 | 15837545 |
| The activity of cancer procoagulant in cases of uterine leiomyomas. | 2005 | 16122189 |
| Properties of proteins in cancer procoagulant preparations that are detected by anti-tissue factor antibodies. | 2004 Aug 15 | 15246868 |